VYOME HOLDINGS, INC. Accrued Liabilities, Current
VYOME HOLDINGS, INC. (HIND) had Accrued Liabilities, Current of $517.34 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Accrued Liabilities, Current $517.34K.
- 2026-03-31: Accrued Liabilities, Current $590.14K.
- 2025-12-31: Accrued Liabilities, Current $639.15K.
- 2025-09-30: Accrued Liabilities, Current $249.19K.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $517.34K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $590.14K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $639.15K 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $249.19K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $333.24K 8-K · filed 2025-09-02 | $1.59M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $2.16M 10-Q · filed 2025-05-20 | |
| 2024-12-31 | $463.69K 10-K · filed 2026-03-18 | $1.69M 10-K · filed 2025-04-04 |
| 2024-09-30 | $1.64M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.90M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.93M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.81M 10-K · filed 2025-04-04 | |
| 2023-09-30 | $2.73M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.53M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $5.32M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $5.04M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $4.87M 10-K · filed 2023-04-17 | $4.85M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $5.83M 10-K · filed 2023-04-17 | $5.81M 10-Q · filed 2022-08-19 |
| 2022-03-31 | $3.48M 10-K · filed 2023-04-17 | $3.46M 10-Q · filed 2022-05-23 |
| 2021-12-31 | $3.37M 10-K · filed 2023-04-17 | $3.17M 10-K · filed 2022-04-08 |
| 2021-09-30 | $3.23M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $53.33M 10-Q · filed 2021-08-16 | |
| 2020-12-31 | $3.63M 10-K · filed 2022-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |